ATS 2019 Virtual Final Program

P463 Determining Eligibility of Patients for a Telemedicine Based Program Post COPD Hospitalization Discharge/ G.A. Fernandez, A. Criner, A. Rastogi, S.P. Duffy, G.J. Criner, Philadelphia, PA, p.A3275 P464 A COPD Symptom Reporting Telemedicine System Reduces COPD and All Cause Healthcare Utilization/ G.A. Fernandez, M.R. Jacobs, Philadelphia, PA, p.A3276 P465 Functional Respiratory Imaging Assessment of Glycopyrrolate and Formoterol Fumarate Metered Dose Inhalers Formulated Using Co-Suspension Delivery Technology in COPD/ W. De Backer, J. De Backer, W. Vos, I. Verlinden, C. Van Holsbeke, B. Mignot, M. Jenkins, S. Ivanov, J. Fitzpatrick, E. St. Rose, U.J. Martin, C. Reisner, Antwerp, Belgium, p.A3277 P466 Comparison of Paper and Tablet Based App Diary Cards in COPD Patients/ G.C. Donaldson, L. Finney, D. Wiseman, I. Pandis, A. Rowe, M. Loza, P. Branigan, S. Avey, C.S. Stevenson, F. Baribaud, J.A. Wedzicha, London, United Kingdom, p.A3278 P467 Evaluation of Clinical Characteristics on Patients with COPD Related Pulmonary Hypertension Using Ultrasound Cardiography/ S. Nakayama, S. Chubachi, K. Sakurai, H. Irie, A. Tsutsumi, M. Hashiguchi, M. Nakamura, N. Miyao, H. Nakamura, K. Asano, K. Fukunaga, Shinzyuku, Japan, p.A3279 P468 The British Lung Foundation Early COPD Consortium - Recruitment and Results from an Initial Pilot/ A.I. Ritchie, G.C. Donaldson, E. El-Emir, P.M. Calverley, J. Vestbo, J.A. Wedzicha, London, United Kingdom, p.A3280 P469 MUCOSAL40 (MUcus, COugh, SLow walking, Age40) - Increasing The Diagnosis of COPD in Primary Care/ S. Vaghela, C.B. Sherter, A.M. Ahasic, Norwalk, CT, p.A3281 P470 Activity Monitoring in COPD: A Feasibility Study/ L. Finney, G.C. Donaldson, D.J. Wiseman, I. Pandis, A. Rowe, M. Loza, P. Branigan, S. Avey, F. Baribaud, C.S. Stevenson, J.A. Wedzicha, London, United Kingdom, p.A3282 P471 Characteristics of GOLD 2017 COPD Group A: A Multicenter Cross-Sectional CAP Study in Japan/ K. Oishi, T. Hirano, K. Hamada, S. Uehara, R. Suetake, Y. Yamaji, K. Ito, M. Asami-Noyama, N. Edakuni, M. Yano, K. Matsunaga, Ube, Japan, p.A3283 P472 A Qualitative Analysis of Patients’ Experience of a COPD Exacerbation and Reasons for Seeking Treatment/ P.W. Jones, Q. Ma, J. Xia, P. Chen, C. Wang, V. Li, M. Tabberer, Brentford, United Kingdom, p.A3284 P473 National Clinical Audit Drives Quality Improvement at Exacerbation of COPD/ J. Hurst, K. Mortier, V. McMillan, M. Roberts, London, United Kingdom, p.A3285 P474 Performance of Bioelectrical Impedance Analysis Compared to DEXA in Individuals with COPD/ P.N. Cruz Rivera, R.L. Goldstein, M.M. Polak, M.L. Moy, E.S. Wan, Boston, MA, p.A3286 P475 Feasibility of Using Home Humidified High Flow Nasal Cannula- Oxygen Therapy (HHFNC-O 2 ) After Recent Acute Exacerbation of COPD (AECOPD) Requiring Hospitalization/ A. Pandya, G.J. Criner, H. Criner, J. Thomas, M.R. Jacobs, Philadelphia, PA, p.A3287 P476 “How’s My Inhaler Technique?”: A Patient Perception Survey/ J.S. Kim, S. Choudhary, N. Hashweh, H. Li, S. Santosh, E. Charbek, St. Louis, MO, p.A3288 P477 Feasibility of Screening Electronic Health Records to Identify Participants for a Multi-Center Clinical Effectiveness Trial in COPD/ S. LaBedz, R.K. Albert, M.V. Avdalovic, S.K. Bellam, N. Bracken, J. Castex, S.E. David, A.E. Dixon, M.B. Drummond, K. Erwin, V. Flores, R.J. Folz, R. Gallardo, L.B. Gerald, M.E. Hanley, M. Hart, U.S. Hatipoglu, R. Henderson, J.T. Holbrook, S. Illendula, E. Malanga, D.M. Mannino, C.A. Meldrum, M.W. Millard, R.A. Mularski, D.R. Ouellette, V.M. Pinto-Plata, V. Prieto-Centurion, N. Putcha, S. Rennard, J. Rommes, G. Roy, L. Seoane, E. Sugar, R.A. Wise, J.A. Krishnan, Chicago, IL, p.A3289 P478 Improving Referrals to Pulmonary Rehabilitation in COPD Patients: A Quality Improvement Project/ C.A. Meldrum, S.K. Huang, M. McInroy, S. Echols, W.W. Labaki, R. Sagana, M.K. Han, Ann Arbor, MI, p.A3290 P479 Heart Rate Variability in COPD Patients Differs with Chronic Bronchitic and Bronchiectatic Phenotypes/ N. Saiphoklang, R. Marzan-McGill, M. Villarreal, M. Dembek, B.A. Dolezal, R.G. Buhr, M.J. Flynn, W. LeMaster, J.A. Belperio, C.B. Cooper, I. Barjaktarevic, Pathumthani, Thailand, p.A3291 P480 COPD Misdiagnosis: The Risks of Autopopulation/ A. Diaz Chavez, F. Vazquez de Lara, N. Garg, E. Eden, New York, NY, p.A3292 P481 Evaluation for Home Oxygen in Veterans with COPD and Moderate Oxygen Desaturation Using Criteria of the Long-Term Oxygen Treatment Trial/ R.L. Perez, H. Karnib, J. Gualdoni, A. Ng, Philadelphia, PA, p.A3293 P482 COPD Diagnostic Accuracy in Hospitalised Patients: A Retrospective and Prospective Single Center Study/ F. Darawshy, R. Kuint, A. Abu Rmeileh, N. Berkman, Jerusalem, Israel, p.A3294 P483 Assessment of COPD Assessment Test (CAT) Scores in Stable Ambulatory Patients with COPD/ M. Singh, A.G. Duarte, P. Wagner, E.S. Hsu, Y.-F. Kuo, G. Sharma, Galveston, TX, p.A3295 P484 Smoking Cessation in COPD Patients with Nicotine Dependence in a Single-Center Clinic in Japan/ H. Tomioka, R. Hashimoto, T. Wada, Kobe, Japan, p.A3296 P485 Effects of Roflumilast on Chronic Bronchitis Symptom in Patients of Chronic Obstructive Pulmonary Disease/ H. Joo, J.W. Kim, K.Y. Kim, Y. Hyoung Kyu, C.K. Rhee, Uijeongbu, Korea, Republic of, p.A3297 P486 Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease/ J.-K. Lee, C.K. Rhee, K. Kim, S.W. Ra, J.H. Lee, K.-S. Jung, K.H. Yoo, Y.-I. Kim, D.K. Kim, Seoul, Korea, Republic of, p.A3298 P487 Performance of a Valved Holding Chamber (VHC) with Tracheostomy Adapter: Aerosol Delivery from Soft Mist Inhalers (SMIs)/ M. Nagel, R. Ali, C. Doyle, D.P. Coppolo, J. Suggett, London, Canada, p.A3299 ATS 2019 • Dallas, TX 160 MONDAY • MAY 20